Format

Send to

Choose Destination
J Allergy Clin Immunol. 2018 May;141(5):1943-1947.e9. doi: 10.1016/j.jaci.2018.01.027. Epub 2018 Feb 7.

Germline gain-of-function myeloid differentiation primary response gene-88 (MYD88) mutation in a child with severe arthritis.

Author information

1
Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md. Electronic address: keith.sikora@nih.gov.
2
Pediatric Translational Research Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
3
VIB Medical Biotechnology Center, Ghent, Belgium; Department of Biochemistry, Ghent University, Ghent, Belgium.
4
Office of Science and Technology, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
5
Center for Molecular Modeling, Ghent University, Zwijnaarde, Belgium.
6
Office of Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
7
Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
8
Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Md.
9
Levine Children's Hospital at Carolinas Medical Center, Charlotte, NC.
PMID:
29427642
PMCID:
PMC5938129
[Available on 2019-05-01]
DOI:
10.1016/j.jaci.2018.01.027

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center